An alternative approach to modelling HbA1c trajectories in patients with type 2 diabetes mellitus

Author:

McEwan Phil12,Bennett Hayley1,Qin Lei3,Bergenheim Klas4,Gordon Jason15,Evans Marc6

Affiliation:

1. Health Economics and Outcomes Research Ltd; Cardiff UK

2. Swansea Centre for Health Economics; Swansea University; Swansea UK

3. Global Health Economics and Payer Analytics, AstraZeneca; Gaithersburg Maryland

4. Global Health Economics and Payer Analytics, AstraZeneca; Gothenburg Sweden

5. School of Medicine; University of Nottingham; Nottingham UK

6. University Hospital Llandough; Cardiff UK

Funder

AstraZeneca Pharmaceuticals

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference26 articles.

1. Diabetes UK Facts and Stats 2016 https://www.diabetes.org.uk/Documents/Position%20statements/DiabetesUK_Facts_Stats_Oct16.pdf

2. Estimating the current and future costs of type 1 and type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs;Hex;Diabet Med,2012

3. National Institute for Health and Care Excellence Type 2 diabetes in adults: management https://www.nice.org.uk/guidance/ng28

4. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS49);Turner;JAMA,1999

5. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy;Kahn;N Engl J Med,2006

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3